Literature DB >> 7996008

Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.

U Römling1, B Fiedler, J Bosshammer, D Grothues, J Greipel, H von der Hardt, B Tümmler.   

Abstract

The epidemiology of chronic colonization of airways with Pseudomonas aeruginosa was monitored in 44 patients with cystic fibrosis (CF) by DraI/SpeI macrorestriction analyses of 489 isolates. Sequential P. aeruginosa isolates (144) that had been collected from 32 CF patients over < or = 2.5 years were investigated, and 12 patients were followed for 8 years after onset of colonization. Forty-eight different genotypes were uncovered from 481 typeable isolates. Ten genotypes were found in > 1 unrelated CF patient. The 6 most frequent clones were identified in 58% of isolates. Ten of the 12 patients monitored for 8 years were harboring their initially acquired P. aeruginosa clone at all times, with subtle shifts of fragment patterns indicating subclonal variation. During colonization, the bacteria gradually lost pyocin and phage typing responses, supporting the view that genotypically discordant P. aeruginosa strains develop a common phenotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996008     DOI: 10.1093/infdis/170.6.1616

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  77 in total

1.  Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis.

Authors:  U Römling; B Tümmler
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  A new highly discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological survey of Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  D Sobral; P Mariani-Kurkdjian; E Bingen; H Vu-Thien; K Hormigos; B Lebeau; F Loisy-Hamon; A Munck; G Vergnaud; C Pourcel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-11       Impact factor: 3.267

3.  Bacteriocin-mediated competition in cystic fibrosis lung infections.

Authors:  Melanie Ghoul; Stuart A West; Helle Krogh Johansen; Søren Molin; Odile B Harrison; Martin C J Maiden; Lars Jelsbak; John B Bruce; Ashleigh S Griffin
Journal:  Proc Biol Sci       Date:  2015-09-07       Impact factor: 5.349

4.  Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms.

Authors:  Rinki Kapoor; Mayken W Wadman; Michelle T Dohm; Ann M Czyzewski; Alfred M Spormann; Annelise E Barron
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

5.  Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections.

Authors:  Dao Nguyen; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

6.  Diagnosis, epidemiology and pathogenesis of bacterial infections in the molecular era.

Authors:  S Sethi; T F Murphy; K L Klingman
Journal:  Clin Mol Pathol       Date:  1996-02

7.  Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections.

Authors:  Christiane Beckmann; Mitchell Brittnacher; Robert Ernst; Nicole Mayer-Hamblett; Samuel I Miller; Jane L Burns
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity.

Authors:  Nathan E Head; Hongwei Yu
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts.

Authors:  Stephan Schwager; Kirsty Agnoli; Manuela Köthe; Friederike Feldmann; Michael Givskov; Aurelien Carlier; Leo Eberl
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

10.  Use of Synthetic Hybrid Strains To Determine the Role of Replicon 3 in Virulence of the Burkholderia cepacia Complex.

Authors:  Kirsty Agnoli; Roman Freitag; Margarida C Gomes; Christian Jenul; Angela Suppiger; Olga Mannweiler; Carmen Frauenknecht; Daniel Janser; Annette C Vergunst; Leo Eberl
Journal:  Appl Environ Microbiol       Date:  2017-06-16       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.